Nunn AJ - Search Results

1

New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects.

Zumla AI, Gillespie SH, Hoelscher M, Philips PP, Cole ST, Abubakar I, McHugh TD, Schito M, Maeurer M, Nunn AJ. Zumla AI, et al. Among authors: nunn aj. Lancet Infect Dis. 2014 Apr;14(4):327-40. doi: 10.1016/S1473-3099(13)70328-1. Lancet Infect Dis. 2014. PMID: 24670627 Review.

2

The ethics of non-inferiority trials.

Nunn AJ, Meredith SK, Spigelman MK, Ginsberg AM, Gillespie SH. Nunn AJ, et al. Lancet. 2008 Mar 15;371(9616):895; author reply 896-7. doi: 10.1016/S0140-6736(08)60404-3. Lancet. 2008. PMID: 18342678 No abstract available.

3

Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial.

Nunn AJ, Mwaba P, Chintu C, Mwinga A, Darbyshire JH, Zumla A; UNZA-UCLMS Project LUCOT Collaboration. Nunn AJ, et al. BMJ. 2008 Jul 10;337:a257. doi: 10.1136/bmj.a257. BMJ. 2008. PMID: 18617486 Free PMC article. Clinical Trial.

4

Design issues in pivotal drug trials for drug sensitive tuberculosis (TB).

Nunn AJ, Phillips PP, Gillespie SH. Nunn AJ, et al. Tuberculosis (Edinb). 2008 Aug;88 Suppl 1:S85-92. doi: 10.1016/S1472-9792(08)70039-8. Tuberculosis (Edinb). 2008. PMID: 18762156 Review.

5

Global tuberculosis drug development pipeline: the need and the reality.

Ma Z, Lienhardt C, McIlleron H, Nunn AJ, Wang X. Ma Z, et al. Among authors: nunn aj. Lancet. 2010 Jun 12;375(9731):2100-9. doi: 10.1016/S0140-6736(10)60359-9. Epub 2010 May 18. Lancet. 2010. PMID: 20488518 Review.

6

Randomised, placebo-controlled trial to evaluate co-trimoxazole to reduce mortality and morbidity in HIV-infected post-natal women in Zambia (TOPAZ).

Nunn AJ, Mwaba PB, Chintu C, Crook AM, Darbyshire JH, Ahmed Y, Zumla AI. Nunn AJ, et al. Trop Med Int Health. 2011 Apr;16(4):518-26. doi: 10.1111/j.1365-3156.2011.02731.x. Epub 2011 Feb 1. Trop Med Int Health. 2011. PMID: 21281407 Free article. Clinical Trial.

7

Challenges of Phase III study design for trials of new drug regimens for the treatment of TB.

Phillips PP, Nunn AJ. Phillips PP, et al. Among authors: nunn aj. Future Med Chem. 2010 Aug;2(8):1273-82. doi: 10.4155/fmc.10.221. Future Med Chem. 2010. PMID: 21426018

8

Innovative trial designs are practical solutions for improving the treatment of tuberculosis.

Phillips PP, Gillespie SH, Boeree M, Heinrich N, Aarnoutse R, McHugh T, Pletschette M, Lienhardt C, Hafner R, Mgone C, Zumla A, Nunn AJ, Hoelscher M. Phillips PP, et al. Among authors: nunn aj. J Infect Dis. 2012 May 15;205 Suppl 2:S250-7. doi: 10.1093/infdis/jis041. Epub 2012 Mar 22. J Infect Dis. 2012. PMID: 22448027

9

Reply to Dodd and Proschan.

Phillips PP, Bratton DJ, Nunn AJ, Hoelscher M. Phillips PP, et al. Among authors: nunn aj. J Infect Dis. 2013 Feb 1;207(3):544-5. doi: 10.1093/infdis/jis705. Epub 2012 Nov 21. J Infect Dis. 2013. PMID: 23175768 No abstract available.

10

An analysis with serious flaws.

Nunn AJ, Phillips PP. Nunn AJ, et al. Clin Infect Dis. 2013 Oct;57(7):1064-5. doi: 10.1093/cid/cit433. Epub 2013 Jun 27. Clin Infect Dis. 2013. PMID: 23811419 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

254 results

Search Page